GlaxoSmithKline plc (GSK) Earnings
|
Expand Research on GSK
| Next EPS Date | 5/1/24 | EPS Growth Rate | +145.9% |
|---|---|---|---|
| Average EPS % Beat Rate | -21.9% | Revenue Growth Rate | +28.8% |
| Average % Move 1-Wk after EPS | -3.2% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10/23/13 | Q313 | $0.31 | N/A | N/A | $10.09B | $10.31B | N/A |  | | Details | |
| 7/27/22 | Q222 | GBP0.78 | GBP0.67 | +GBP0.11 | GBP11.22B | GBP9.86B | N/A | | | Details | |
| 1/31/24 | Q423 | N/A | GBP0.74 | N/A | N/A | GBP9.61B | N/A | N/A | N/A | ||
| 11/1/23 | Q323 | GBP0.50 | GBP1.10 | -GBP0.60 | GBP8.15B | GBP9.31B | N/A | | | Details | |
2/5/20  |
Q419 | GBP0.25 | GBP0.25 | GBP0.00 | GBP8.9B | GBP9.02B | N/A | | | Details | |
| 5/1/24 | Q124 | N/A | GBP0.91 | N/A | N/A | GBP8.95B | N/A | N/A | N/A | ||
| 2/1/23 | Q422 | N/A | GBP0.54 | N/A | N/A | GBP8.88B | N/A | N/A | N/A | ||
| 7/26/23 | Q223 | N/A | GBP0.89 | N/A | N/A | GBP8.78B | N/A | N/A | N/A |
